These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Pancreatic oncofetal antigen and carcinoembryonic antigen in breast and colon carcinoma.
    Author: Kithier K, Samal B, Cejka J, Whitcomb MP, Mood DW.
    Journal: Tumour Biol; 1988; 9(6):307-14. PubMed ID: 3206109.
    Abstract:
    Pancreatic oncofetal antigen (POA) and carcinoembryonic antigen (CEA) were determined in plasma of 195 patients with breast cancer and 90 patients with colon carcinoma. Increased levels of POA and CEA were seen in 19.0 and 25.6% of patients with breast cancer, respectively. Some but not all patients showed an increase in both markers. The incidence of abnormal concentrations of POA and CEA increased with the progress of the disease. POA appears to be a useful marker in breast cancer, especially in patients who have normal CEA levels. On the other hand, colon carcinoma patients showed increased POA concentrations considerably less frequently than CEA levels.
    [Abstract] [Full Text] [Related] [New Search]